We envision that an anti AQP5 therapeutic antibody or small molecular inhibitors targeted to AQP5 expression among BC patients with strong AQP5 expression or genomic implications may open door to new levels of anti-breast cancer therapeutics [40]. Here, AQP5 is linked to breast carcinoma.